MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Patient-Derived α-Synuclein Kinetic Subtypes Drive Distinct Pathological Propagation Patterns and Brain Network Alterations in Parkinson’s Disease Mouse Models

    W. Dai (Urumqi, China)

    Objective: To validate whether patient-derived α-synuclein (α-Syn) aggregates with distinct kinetic properties produce differentiated pathological propagation patterns, brain network functional alterations, and behavioral phenotypes in…
  • 2026 International Congress

    Complete and sustained remission of cervical dystonia after repeated dual-target low-frequency rTMS (right M1 + left cerebellum): a 2-year follow-up case report

    Y. Wu, M. Zhang, H. Sun, Z. Zheng, H. Shang (Chengdu, China)

    Objective: To report the clinical course and long-term outcome of repeated 1 Hz rTMS (right M1 + left cerebellum) in a botulinum toxin-naïve idiopathic cervical…
  • 2026 International Congress

    The Role of Electrophysiology in Preventing Diagnostic Misclassification of a Craniocervical Dystonia

    A. Talaugon*, A. Young*, S. Jaradeh, N. Samudra, B. Razavi, P. Kahali (Palo Alto, USA)

    Objective: To illustrate the utility of EMG/NCS in diagnosing a paroxysmal craniocervical dystonia confounded by features mimicking  seizure and functional movement disorder (FMD). Background: A…
  • 2026 International Congress

    Factors Associated with Efficacy and Safety of Unilateral Thalamic MRgFUS in Essential Tremor: A Single-Center Cohort Study

    M. Gea, L. Ispierto, M. Tardáguila, A. Gonzalez, J. Muñoz, R. García, J. Ríos, C. Villa, R. álvarez, D. Vilas (Barcelona, Spain)

    Objective: To identify factors associated with treatment efficacy and safety of unilateral thalamic magnetic resonance-guided focused ultrasound (MRgFUS) in patients with essential tremor (ET). Background:…
  • 2026 International Congress

    APOSTIM study: a prospective study on quality of life in Parkinsonian patients sequentially treated with apomorphine infusion and STN stimulation

    F. Fluchere, S. Drapier, C. Moreau, F. Ory-Magne, E. Hainque, A. Marques Gagniere, B. Jarraya, S. Thobois, S. Ansquer, C. Giordana, D. Guehl, S. Frismand, T. Rouaud, M. Tir, A. Roland, D. Devos, A. Eusebio, JP. Azulay (Marseille, France)

    Objective: The APOSTIM study aimed to compare the quality of life (QoL) in Parkinson’s disease (PD) patients treated sequentially with continuous subcutaneous apomorphine infusion (CSAI)…
  • 2026 International Congress

    Voice-Based Screening of Parkinsonian Disorders Using Acoustic Feature Analysis and Machine Learning

    L. Cruz-Mondragon, A. Shih, V. Santini, S. Panchawagh (Winston Salem, USA)

    Objective: To evaluate whether acoustic features from voice recordings can distinguish Parkinson’s disease and related parkinsonian disorders from healthy controls. Background: Speech production depends on…
  • 2026 International Congress

    Omaveloxolone in a real-world setting: implications in Friedreich Ataxia beyond the classic study population

    W. Nachbauer, M. Amprosi, D. Boesch, M. Schranz, E. Indelicato, L. Schwaighofer, S. Boesch (Innsbruck, Austria)

    Objective: The aim was to monitor safety and efficacy of omaveloxolone treatment in a single center real life cohort, focusing on Friedreich Ataxia (FRDA) patients…
  • 2026 International Congress

    Dual device-aided therapy in advanced Parkinson’s Disease: combining bilateral deep brain stimulation and continuous subcutaneous foslevodopa/foscarbidopa Infusion

    C. Ribacoba Díaz, A. Fernández Revuelta, A. Aldaz Burgoa, E. López Valdés, R. García-Ramos García (Madrid, Spain)

    Objective: To describe our experience with dual device-aided therapies (DATs). Background: DATs for advanced Parkinson's disease (PD) include deep brain stimulation, continuous subcutaneous apomorphine infusion…
  • 2026 International Congress

    Disparate Subregional Striatal DAT-SPECT Associations with CSF-Synucleinopathy Status and Clinical Severity Across Parkinson’s Disease Continuum

    AD. Droby, BK. Krayem, AM. Mirelman, AT. Thaler (Tel Aviv, Israel)

    Objective: To determine the association between subregional DAT binding ratios (SBRs) for disease risk, PD progression, and whether these associations differ based on SAA status.…
  • 2026 International Congress

    Evaluating Gene-Environment Interactions between Head Injury and Parkinson’s Disease Risk Variants.

    A. Kuri, S. Waters, L. Jones, N. Del Rey, L. Screven, H. Iwaki, M. Nalls, A. Noyce (London, United Kingdom)

    Objective: To evaluate gene-environment interactions between head injury and candidate single nucleotide polymorphisms (SNP) in Parkinson’s disease (PD). Background: Head injury is consistently associated with…
  • « Previous Page
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley